Lancer Orthodontics, Inc.

LANZ · OTC
Analyze with AI
5/31/2004
5/31/2003
5/31/2002
5/31/2001
Valuation
PEG Ratio-0.910.26-0.130.06
FCF Yield-26.93%49.09%13.27%15.64%
EV / EBITDA34.964.412.8916.52
Quality
ROIC0.98%0.52%3.13%3.17%
Gross Margin31.48%29.62%30.94%32.62%
Cash Conversion Ratio-2.659.232.41-0.60
Growth
Revenue 3-Year CAGR0.01%-0.22%2.15%-1.49%
Free Cash Flow Growth-203.40%419.49%44.03%-54.81%
Safety
Net Debt / EBITDA-7.35-5.39-0.300.35
Interest Coverage18.404.555.674.90
Efficiency
Inventory Turnover2.232.371.991.87
Cash Conversion Cycle201.56189.32219.37224.87